Actuate Therapeutics Inc. Common stock (ACTU)
Stock · NASDAQ · Health Care
$1.67as of 8/28/2026
Price chart
Open in TradingViewActive signals
High Beta24.0%
Resistance level
$1.94
Industry
Biotechnology: Pharmaceutical Preparations
About ACTU
Actuate Therapeutics, Inc., a clinical-stage biopharmaceutical company, develops therapies for the treatment of cancers in the United States. The company's lead product candidate is elraglusib injection, a glycogen synthase kinase-3 inhibitor that is in Phase 2 trial to treat metastatic pancreatic ductal adenocarcinoma. It also develops elraglusib, which is in Phase 1/2 trial for the treatment of refractory pediatric…
- Sector
- Health Care
- Industry
- Biotechnology: Pharmaceutical Preparations
- Employees
- 12
- Website
- actuatetherapeutics.com/
Fundamentals
- 1-day range
- $1$1.1
- Market cap
- $29.43M
- P/E (trailing)
- —
- P/E (forward)
- -1.45
- EPS (trailing)
- $-0.99
- Dividend yield
- —
- Beta
- 1.40
- Avg. volume
- 266.4K
52-week range
$0.9$9.22
Next earnings: November 12, 2026 · EPS estimate $-0.15confirmed
Forecasts
4 analyst ratings
Buy 90%
Hold 10%
Sell 0%
1-year price forecast
High
$15.05
+801.2%
Median
$10
+498.8%
Low
$5
+199.4%
Actuate Therapeutics Inc. Common stock Competitors
Chosen by industry and closest market cap.
- ACTUActuate Therapeutics Inc. Common stock$1.67▼ 1.18%Market cap $29.43MP/E —$0.9$9.22
- BCTXBriaCell Therapeutics Corp. Common Shares$3.73▲ 0.54%Market cap $30.01MP/E —$3.68$20.4
- MIRAMIRA Pharmaceuticals Inc. Common Stock$0.75▼ 2.60%Market cap $28.50MP/E —$0.6$2.45
- GRCEGrace Therapeutics Inc. Common Stock$2.13▼ 1.39%Market cap $28.44MP/E —$1.79$5.18
- RMTIRockwell Medical Inc. Common Stock$8.22▲ 6.06%Market cap $28.26MP/E —$4.89$21
- KYNBKyntra Bio Inc. Common Stock$8.02▲ 1.26%Market cap $28.26MP/E 0.17$6.32$12.6
- ABVCABVC BioPharma Inc. Common Stock$0.8251▲ 3.66%Market cap $27.09MP/E —$0.7069$3.4
| Symbol | Market cap | P/E ratio | Price | 1D | 52-week range |
|---|---|---|---|---|---|
| ACTU Actuate Therapeutics Inc. Common stock | $29.43M | — | $1.67 | ▼ 1.18% | $0.9$9.22 |
| BCTX BriaCell Therapeutics Corp. Common Shares | $30.01M | — | $3.73 | ▲ 0.54% | $3.68$20.4 |
| MIRA MIRA Pharmaceuticals Inc. Common Stock | $28.50M | — | $0.75 | ▼ 2.60% | $0.6$2.45 |
| GRCE Grace Therapeutics Inc. Common Stock | $28.44M | — | $2.13 | ▼ 1.39% | $1.79$5.18 |
| RMTI Rockwell Medical Inc. Common Stock | $28.26M | — | $8.22 | ▲ 6.06% | $4.89$21 |
| KYNB Kyntra Bio Inc. Common Stock | $28.26M | 0.17 | $8.02 | ▲ 1.26% | $6.32$12.6 |
| ABVC ABVC BioPharma Inc. Common Stock | $27.09M | — | $0.8251 | ▲ 3.66% | $0.7069$3.4 |
P/E shows — for peers not currently carrying a live signal of their own.
Latest news
- 12 Health Care Stocks Moving In Thursday's Intraday SessionBenzinga · 8/20/2026
- HC Wainwright & Co. Reiterates Buy on Actuate Therapeutics, Maintains $15 Price Targetbenzinga · 8/18/2026
- HC Wainwright & Co. Reiterates Buy on Actuate Therapeutics, Maintains $15 Price TargetBenzinga · 8/18/2026
Insider Activity
Insider Actions →Acquired
824.1K
Disposed
120.5K
- SCHMITT DANIEL M · August 14, 2026 · Option Exercise272.1K
- SCHMITT DANIEL M · August 14, 2026 · Tax Withholding120.5K @ $1.01
- Zabrowski Dan · May 21, 2026 · Grant15.0K
- Sawhney Roger · May 21, 2026 · Grant15.0K
- Keyes Jason A · May 21, 2026 · Grant15.0K
- Martin H. Huber Jr. · May 21, 2026 · Grant15.0K
- Aaron G.L. Fletcher · May 21, 2026 · Grant15.0K
- RONNEBERG AMY L · May 21, 2026 · Grant15.0K
- THOMSON TODD S · May 21, 2026 · Grant15.0K
- Mazar Andrew Paul · April 1, 2026 · Grant105.0K
- SCHMITT DANIEL M · April 1, 2026 · Grant237.0K
- LYTLE PAUL J · April 1, 2026 · Grant105.0K
Institutional Ownership
March 31, 2026
- Total shares held
- 13.73M
- Total value held
- $37.62M
- Institutional holders
- 57
Top holders this quarter
- Unknown10.05M
- Unknown1.73M
- Unknown427.2K
- Unknown400.5K
- Unknown228.3K
- Unknown113.3K
- Unknown100.0K
- Unknown97.9K
- Unknown94.6K
- Unknown66.0K
See the full, filterable feed with live charts on the MarketWall dashboard.